Explore 3 Stock Ideas & Industry Insights Download Free Report

Earnings

Why After-Hours Earnings Reactions Like SMCI, PEGA, and ALK Can Diverge So Sharply From the Headline Numbers

A recurring pattern across this after-hours session, visible in the moves for Super Micro Computer, Pegasystems, and Alaska Air Group alike, is that forward guidance, rather than the headline results for the quarter just completed, often drives the sharpest share price reactions during earnings …

Nitish Kishor | 21 July 2026

Super Micro Computer (NASDAQ: SMCI) Stock Surges 17% After Hours on Blowout Q4 Margin Guidance and Record $60 Billion Order Backlog

Super Micro Computer (NASDAQ: SMCI) shares rocketed higher in after-hours trading, adding to a roughly 20% intraday gain, following a bullish preliminary update on its fiscal fourth-quarter 2026 results. While fourth-quarter revenue is expected to land near the low end of the company's previously …

Nitish Kishor | 21 July 2026

Oklo (NYSE: OKLO) and X-Energy (NASDAQ: XE) Stocks Surge on $200 Million Federal Nuclear Program for AI Data Centers

Nuclear energy developers Oklo (NYSE: OKLO) and X-Energy (NASDAQ: XE) surged in trading, up 8% and 12% respectively, following reports that both companies are joining a $200 million federal program aimed at accelerating nuclear reactor development for AI data centers. The news taps directly …

Nitish Kishor | 21 July 2026

Pegasystems (NASDAQ: PEGA) Stock Drops Over 13% After Hours on Q2 Earnings Miss Amid Cloud Transition

Pegasystems (NASDAQ: PEGA) shares slid sharply in after-hours trading, down more than 13%, after the company reported second-quarter results that missed Wall Street expectations on both the top and bottom lines. Adjusted earnings per share came in at $0.35 versus the $0.43 analysts had …

Nitish Kishor | 21 July 2026

Celldex Therapeutics (NASDAQ: CLDX) Stock Falls 8% as Phase 2 Barzolvolimab Trial Misses Endpoints in Prurigo Nodularis

Celldex Therapeutics (NASDAQ: CLDX) shares fell 8% after the company announced that its Phase 2 study evaluating subcutaneous barzolvolimab in prurigo nodularis, a chronic inflammatory skin condition, failed to meet both its primary and secondary endpoints. The result marks a significant setback for one …

Nitish Kishor | 21 July 2026

Alaska Air Group (NYSE: ALK) Stock Slides 4% on Disappointing Q3 Earnings Outlook Despite Q2 Beat

Alaska Air Group (NYSE: ALK) slid 4% after issuing a disappointing near-term earnings outlook that overshadowed a better-than-expected second-quarter result. The carrier reported Q2 adjusted earnings per share of negative $0.92, slightly ahead of the negative $0.98 consensus estimate, on revenue of $4.07 billion, …

Nitish Kishor | 21 July 2026

Forestar Group (NYSE: FOR) Misses Q3 EPS, Shares Slide 3.9%

Forestar Group Inc. posted earnings per share of $0.70 for the quarter ended June 30, 2026, shy of the $0.82 consensus forecast. The miss prompted an immediate 3.9% slide, valuing the stock at $27.11 in the latest session.

Vinay Lochav | 21 July 2026

GM Q2 Revenue Hits $48B as North America Profits Surge 43%

General Motors delivered a quarter that underscored the resilience of U.S. consumer demand, reporting $48 billion in revenue and a 43% surge in North America profits. The results sent a signal to investors that pricing power in the auto sector remains intact, even as …

Vinay Lochav | 21 July 2026

KeyCorp (NYSE: KEY) Beats Q2 Estimates With $0.44 EPS, Shares Dip 1.7%

KeyCorp’s second-quarter results delivered a profit surge and margin expansion, but investors sent shares lower as the regional bank’s performance lagged larger rivals. Revenue climbed 7% to $1.96 billion, fueled by a 9% increase in net interest income, while the net interest margin ticked …

Vinay Lochav | 21 July 2026

Park Aerospace (NYSE: PKE) Posts EPS $0.17, Beats Consensus

Park Aerospace Corp. Net sales for the period were $18,312,000, an increase from $15,400,000 recorded a year earlier. Adjusted EBITDA reached $4,576,000, reflecting operational improvements over the prior year’s figures.

Vinay Lochav | 21 July 2026
Support

Hi! How can we help you today?

Loading…